meta[bolic
This company provides continuous, data-driven care models for managing and transforming metabolic conditions like diabetes and obesity. They integrate physicians, nutritionists, and scientists with real-time data from wearables and advanced diagnostics to deliver hyper-personalized lifestyle medicine. The focus is on achieving superior patient outcomes through ongoing engagement and actionable insights derived from comprehensive health monitoring.
- Digital Health
- Healthcare Technology
- Software Only
Funding
Founders
Product
Problem
Managing metabolic diseases like diabetes and obesity often requires intensive, personalized care that is difficult to deliver at scale. Traditional healthcare approaches may lack the data-driven insights and continuous monitoring needed to optimize treatment plans and achieve lasting behavioral changes.
Solution
Metabolic operates two platforms: GluCare.Health, an ICHOM-accredited platform for diabetes management, and Zone.Health, a direct-to-consumer program for medicated weight management. GluCare.Health uses a data-driven approach and technology integration to provide personalized diabetes care and improve health outcomes. Zone.Health focuses on promoting health and longevity through a range of services, including medically managed peptides and hormone health, with a focus on weight loss. Both platforms aim to address metabolic diseases through personalized care, technology, and data-driven insights.
Target Audience
GluCare.Health targets individuals with diabetes, while Zone.Health focuses on consumers seeking weight management solutions and improved metabolic health.
Features
- ICHOM-accredited diabetes management platform (GluCare.Health)
- Direct-to-consumer medicated weight management program (Zone.Health)
- Personalized care plans based on data-driven insights
- Continuous patient monitoring and engagement
- In-house laboratory and pharmacy
- Telehealth support and remote consultations
- Integration of technology to enhance the patient journey
- Programs for hormone health, peptide therapy, and clinical longevity